- Home
- CELC vs OTLY Comparison
CELC vs OTLY Comparison
Compare CELC & OTLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CELC | OTLY |
|---|---|---|
| Founded | 2011 | 1994 |
| Country | United States | Sweden |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 368.8M |
| IPO Year | 2017 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CELC | OTLY |
|---|---|---|
| Price | $105.07 | $11.68 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 5 |
| Target Price | ★ $100.13 | $15.50 |
| AVG Volume (30 Days) | ★ 945.1K | 63.1K |
| Earning Date | 11-12-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $842,996,000.00 |
| Revenue This Year | N/A | $4.69 |
| Revenue Next Year | N/A | $4.65 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 3.63 |
| 52 Week Low | $7.58 | $6.00 |
| 52 Week High | $112.64 | $18.84 |
Technical Indicators
Market Signals| Indicator | CELC | OTLY |
|---|---|---|
| Relative Strength Index (RSI) | 70.65 | 36.12 |
| Support Level | $100.00 | $11.56 |
| Resistance Level | $108.91 | $12.43 |
| Average True Range (ATR) | 5.14 | 0.51 |
| MACD | -0.88 | 0.07 |
| Stochastic Oscillator | 54.47 | 11.63 |
Price Performance
Historical ComparisonAbout CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About OTLY Oatly Group AB
Oatly Group AB is engaged in the food and drinks industry. Some of its products include Oat Drink, Chilled Oat Drink, Oatgurt, Creamy Oat, and Icecreams, among others. It caters to Sweden, Germany, the United Kingdom, Netherlands, North America, Finland, and Other markets. The company generates revenue from the EMEA, Americas, and Asia regions, with the majority of revenue generated from the EMEA region.